Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andreas Lundqvist

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 19

Top Venues

Oncoimmunology

Cancer immunology research

Journal for immunotherapy of cancer

Cancers

Karolinska Institutet

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet May 24o 2012

Sweden

Associate Professor :: Oncology-Pathology

Education History

Karolinska Institutet Mar 1o 1998 - Jan 31o 2003

Sweden

PHD :: Oncology-Pathology

Publications

Ziqing Chen, Le Tong, Shi Yong Neo, Shuijie Li, Jiwei Gao, Susanne Schlisio, Andreas Lundqvist
CD25 bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression. Oncoimmunology 12 (1) (2023)
Le Tong, Veronika Kremer, Shi Yong Neo, Yaxuan Liu, Yi Chen, Arnika Kathleen Wagner, Ying Yang, Ziqing Chen, Christina Seitz, Nicholas Patrick Tobin, Maarten Alexander Ligtenberg, Evren Alici, Xinsong Chen, Felix Haglund, Barbara Seliger, Ulrika Harmenberg, Eugenia Colón, Ann-Helén Scherman Plogell, Lisa Lei Liu, Andreas Lundqvist
Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1. Cancer communications (London, England) (2023)
Weiyingqi Cui, Aravindh Subramani, Pedro Fonseca, Yumeng Zhang, Le Tong, Yuanyuan Zhang, Lars Egevad, Andreas Lundqvist, Lars Holmgren
Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment. Cells 12 (17) (2023)
Rosanne E Veerman, Gözde Güclüler Akpinar, Annemarijn Offens, Loïc Steiner, Pia Larssen, Andreas Lundqvist, Mikael C I Karlsson, Susanne Gabrielsson
Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model. Cancer immunology research 11 (2) (2023)
Rosanne E Veerman, Gözde Güclüler Akpinar, Annemarijn Offens, Loïc Steiner, Pia Larssen, Andreas Lundqvist, Mikael C I Karlsson, Susanne Gabrielsson
Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model. Cancer immunology research 11 (2) (2023)
Rosanne E Veerman, Gözde Güclüler Akpinar, Annemarijn Offens, Loïc Steiner, Pia Larssen, Andreas Lundqvist, Mikael C I Karlsson, Susanne Gabrielsson
Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model. Cancer immunology research 11 (2) (2023)
Ziqing Chen, Le Tong, Shi Yong Neo, Shuijie Li, Jiwei Gao, Susanne Schlisio, Andreas Lundqvist
CD25 bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression. Oncoimmunology 12 (1) (2023)
Apple Hui Min Tay, Rubén Prieto-Díaz, Shiyong Neo, Le Tong, Xinsong Chen, Valentina Carannante, Björn Önfelt, Johan Hartman, Felix Haglund, Maria Majellaro, Jhonny Azuaje, Xerardo Garcia-Mera, Jose M Brea, Maria I Loza, Willem Jespers, Hugo Gutiérrez-de-Terán, Eddy Sotelo, Andreas Lundqvist
A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. Journal for immunotherapy of cancer 10 (5) (2022)
Stefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, Jonas Mattsson, Andreas Lundqvist, Elias S J Arnér, Rolf Kiessling, Stina Linnea Wickström
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress. Journal for immunotherapy of cancer 10 (6) (2022)
Rosanne E Veerman, Gözde Güclüler Akpinar, Annemarijn Offens, Loïc Steiner, Pia Larssen, Andreas Lundqvist, Mikael C I Karlsson, Susanne Gabrielsson
Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti-PD-1 and Anti-PD-L1 Treatment in a Checkpoint Refractory Melanoma Model. Cancer immunology research (2022)
Shi Yong Neo, Xu Jing, Le Tong, Dongmei Tong, Juan Gao, Ziqing Chen, Mireia Cruz De Los Santos, Nutsa Burduli, Sabrina De Souza Ferreira, Arnika Kathleen Wagner, Evren Alici, Charlotte Rolny, Yihai Cao, Andreas Lundqvist
Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells. Journal for immunotherapy of cancer 10 (10) (2022)
Khang Luu, Mugdha Vijay Patwardhan, Qun Zeng, Stina Linnea Wickström, Andreas Lundqvist, Herbert Schwarz
Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis. Cells 10 (2) (2021)
Ziqing Chen, Ying Yang, Shi Y Neo, Hao Shi, Yi Chen, Arnika K Wagner, Karin Larsson, Le Tong, Per-Johan Jakobsson, Evren Alici, Jing Wu, Yihai Cao, Kai Wang, Lisa L Liu, Yumeng Mao, Dhifaf Sarhan, Andreas Lundqvist
Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25+ /CD54+ NK cells. EMBO reports 22 (3) (2021)
Yanhong Su, Panagiotis Tsagkozis, Andri Papakonstantinou, Nicholas P Tobin, Okan Gultekin, Anna Malmerfelt, Katrine Ingelshed, Shi Yong Neo, Johanna Lundquist, Wiem Chaabane, Maya H Nisancioglu, Lina W Leiss, Arne Östman, Jonas Bergh, Saikiran Sedimbi, Kaisa Lehti, Andreas Lundqvist, Christina L Stragliotto, Felix Haglund, Monika Ehnman
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma. Cancers 13 (5) (2021)
Ying Yang, Andreas Lundqvist
Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy. Cancers 12 (12) (2020)
Tanja Lövgren, Maria Wolodarski, Stina Linnea Wickström, Ulrika Edbäck, Mette Wallin, Eva Martell, Katrin Markland, Pontus Blomberg, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Gustav Ullenhag, Per Ljungman, Johan Hansson, Giuseppe V Masucci, Roger Tell, Isabel C Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination. Oncoimmunology 9 (1) (2020)
Yago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, Takahiro Nakajima, Stamatina Rentouli, Andreas Lundqvist, Giuseppe V Masucci, Johan Hansson, Rolf Kiessling
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates. Oncoimmunology 9 (1) (2020)
Veronika Kremer, Maarten A Ligtenberg, Rosa Zendehdel, Christina Seitz, Annet Duivenvoorden, Erik Wennerberg, Eugenia Colón, Ann-Helén Scherman-Plogell, Andreas Lundqvist
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal for immunotherapy of cancer 5 (1) (2017)
Yumeng Mao, Vincent van Hoef, Xiaonan Zhang, Erik Wennerberg, Julie Lorent, Kristina Witt, Laia Masvidal, Shuo Liang, Shannon Murray, Ola Larsson, Rolf Kiessling, Andreas Lundqvist
IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells. Blood 128 (11) (2016)

Andreas Lundqvist.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Lundqvist